Sleep architecture in patients with interstitial lung disease with and without pulmonary hypertension

被引:2
|
作者
Simonson, Joseph L. [1 ]
Pandya, Dhwani [2 ]
Khan, Sarah [1 ]
Verma, Sameer [1 ]
Greenberg, Harly E. [1 ]
Talwar, Arunabh [1 ]
机构
[1] Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Med, Div Pulm Crit Care & Sleep Med, 410 Lakeville Rd,Suite 107, New Hyde Pk, NY 10040 USA
[2] Northwell Hlth Staten Isl Univ Hosp, Dept Med, 475 Seaview Ave, Staten Isl, NY 10305 USA
关键词
Interstitial lung disease; Nocturnal hypoxemia; Obstructive sleep apnea; Pulmonary hypertension; Sleep-disordered breathing;
D O I
10.1007/s11325-021-02555-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose Sleep disturbance is common in patients with advanced interstitial lung disease (ILD) often complicated by pulmonary hypertension (PH) and may contribute to poor quality of life. The etiology of sleep disturbance and the relationship between PH and sleep architecture in patients with ILD remains unknown. Methods We performed a retrospective cohort study comparing sleep architecture on polysomnography in patients with ILD with and without PH, defined as mean pulmonary artery pressure on right heart catheterization >= 20 mmHg. We tested the hypothesis that patients with ILD and PH would have increased wake time after sleep onset (WASO) compared to patients with ILD without PH using univariate analysis and multivariable linear regression. Results In our cohort of patients with ILD who underwent polysomnography (N = 49), patients with PH had lower total diffusion capacity for carbon monoxide (DLCO) (9.28 vs. 12.87 ml/min/mmHg, P = 0.04) and percent DLCO (39% vs. 53%, P = 0.03). On polysomnography, patients with PH had increased percentage of total sleep time with saturation < 90% (T90) (17% vs. 6%, P = 0.03), decreased N2 sleep (181 vs. 233 min, P = 0.03), decreased %N2 sleep (59% vs. 66%, P = 0.04), increased %N1 sleep (22% vs. 14%, P = 0.02), decreased sleep efficiency (62% vs. 72%, P = 0.03), and increased WASO (133 vs. 84 min, P = 0.01). In multivariable analysis, PH was associated with a 43-min increase in WASO (95% CI 6.2-80.2, P = 0.02). Conclusion Patients with ILD and PH have decreased total and %N2 sleep, increased %N1 sleep, decreased sleep efficiency, and increased WASO, likely indicating increased sleep fragmentation.
引用
收藏
页码:1711 / 1715
页数:5
相关论文
共 50 条
  • [1] Sleep architecture in patients with interstitial lung disease with and without pulmonary hypertension
    Joseph L. Simonson
    Dhwani Pandya
    Sarah Khan
    Sameer Verma
    Harly E. Greenberg
    Arunabh Talwar
    Sleep and Breathing, 2022, 26 : 1711 - 1715
  • [2] Predictors of mortality in interstitial lung disease patients without pulmonary hypertension
    Alhamad, Esam H.
    Cal, Joseph G.
    ANNALS OF THORACIC MEDICINE, 2020, 15 (04) : 238 - 243
  • [3] Effect of pulmonary rehabilitation program in patients with interstitial lung disease with or without pulmonary hypertension
    Mona Abd Elsalam Taha El Gazzar
    Wafaa Saleh El Shimy
    Hanan Mohamed Elsaadany
    Mohamed Sayed Hantera
    Basem Ibrahim Elshafey
    The Egyptian Journal of Bronchology, 19 (1)
  • [4] Pulmonary hypertension in patients with interstitial lung disease
    Karampitsakos, Theodoros
    Tzouvelekis, Argyrios
    Chrysikos, Serafeim
    Bouros, Demosthenes
    Tsangaris, Iraklis
    Fares, Wassim H.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 50 : 38 - 46
  • [5] Pulmonary hypertension due to interstitial lung disease
    King, Christopher S.
    Nathan, Steven D.
    CURRENT OPINION IN PULMONARY MEDICINE, 2019, 25 (05) : 459 - 467
  • [6] Pulmonary hypertension in interstitial lung disease
    Behr, J.
    Ryu, J. H.
    EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (06) : 1357 - 1367
  • [7] Scleroderma patients with combined pulmonary hypertension and interstitial lung disease
    Chang, B
    Wigley, FM
    White, B
    Wise, RA
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (11) : 2398 - 2405
  • [8] Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection
    Parikh, Raj
    Konstantinidis, Ippokratis
    O'Sullivan, David M.
    Farber, Harrison W.
    PULMONARY CIRCULATION, 2022, 12 (04)
  • [9] Pulmonary hypertension in interstitial lung disease
    Polomis, David
    Runo, James R.
    Meyer, Keith C.
    CURRENT OPINION IN PULMONARY MEDICINE, 2008, 14 (05) : 462 - 469
  • [10] Risk factors of pulmonary hypertension in interstitial lung disease
    Ang, H.
    Schulte, M.
    Chan, R.
    Tan, H.
    Harrison, A.
    Ryerson, C.
    Khor, Y.
    RESPIROLOGY, 2024, 29 : 80 - 80